Farkas Charles 4
4 · CONMED Corp · Filed May 30, 2025
Insider Transaction Report
Form 4
CONMED CorpCNMD
Farkas Charles
Director
Transactions
- Tax Payment
Common Stock
2025-05-29$57.69/sh−966$55,729→ 16,380 total - Exercise/Conversion
Common Stock
2025-05-29$55.70/sh+1,000$55,700→ 17,346 total - Exercise/Conversion
SARs (Stock Appreciation Rights)
2025-05-29−1,000→ 0 totalExercise: $55.70From: 2016-06-01Exp: 2025-06-01→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.